SAGES review of endoscopic and minimally invasive bariatric interventions: a review of endoscopic and non-surgical bariatric interventions
- 380 Downloads
With obesity continuing as a global epidemic and therapeutic technologies advancing, several novel endoscopic and minimally invasive interventions will likely become available as treatment options. With improved technologies and different treatment strategies, as well as different patient populations being targeted, there will be greater application in the treatment armamentarium of specialists dedicated to treating obesity. We sought to review the existing technology and provide a review.
Literature review was carried out for endoscopic and minimally invasive devices. Some of these products are not FDA approved, so limited data are available in their review.
A summary of the device and data currently available on weight loss and safety profile is provided. Several products are in clinical trials or will be soon. Some of the technology has limited data and companies will be submitting their results for FDA evaluation.
The obesity epidemic and associated weight-related diseases represent a tremendous burden to health care practitioners. As such, a multi-modal and progressive approach, with data and outcomes examined, is likely the best and most comprehensive method to care for these patients. SAGES endorses the benefits of minimally invasive and endoscopic approaches in the treatment of obesity and its related co-morbidities.
KeywordsEndoscopic obesity treatment Bariatric endoscopic therapy
This article came from work done within the SAGES and ASMBS Endoscopic Bariatric Task Forces.
Compliance with ethical standards
Marina Kurian has been faculty for Apollo Endosurgery. Kevin Reavis has been faculty for Apollo Endosurgery, and is a PI for EndoBarrier multicenter trial. Matthew Kroh, Bipan Chand, Dean Mikami, and Leena Khaitan have no conflicts of interest or financial ties to disclose.
- 4.Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ (2017) Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 112(3):447–457. https://doi.org/10.1038/ajg.2016.500.CrossRefGoogle Scholar
- 10.Thompson C. https://clinicaltrials.gov/ct2/show/NCT01662024. Last update 30 March 2017. Last accessed 12 Jan 2018
- 11.Huberty V. https://clinicaltrials.gov/ct2/show/NCT03255005. Last update 25 Sept 2007. Last accessed 12 Jan 2018
- 12.Novikov AA, Afaneh C, Saumoy M, Parra V, Shukla A, Dakin GF, Pomp A, Dawod E, Shah S, Aronne LJ, Sharaiha RZ (2017) Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg. https://doi.org/10.1007/s11605-017-3615-7 CrossRefPubMedGoogle Scholar
- 17.https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/ucm540655.htm. Accessed 1 Jan 2018
- 18.https://www.fda.gov/medicaldevices/safety/letterstohealthcareproviders/ucm570707.htm. Accessed 1 Jan 2018